Julius Clinical Research BV

P95 Julius Clinical is a global, science-led contract research organization (CRO) supporting clinical development from early-phase trials through late-phase and real-world evidence programs. The company specializes in complex research for biotech and pharmaceutical sponsors, with deep expertise across neuroscience, infectious diseases and vaccines, and cardiovascular, renal, and metabolic diseases. Backed by a leadership of scientific luminaries and more than 500 experts spanning five continents, P95 Julius Clinical combines the reach of a larger CRO with the agility of a mid-sized partner. Julius Clinical was founded in 2008 as a spin-off from UMC Utrecht, built on a strong academic foundation and a commitment to advancing science through clinical research. Through its merger with P95, it combined Julius Clinical's expertise in global clinical development with P95's leadership in epidemiology, vaccines, infectious diseases, and real-world evidence. Together, they form a science-led global CRO with more than 500 professionals across 25+ countries.

Julius Clinical was founded in 2008 as a spin-off from UMC Utrecht, built on a strong academic foundation and a commitment to advancing science through clinical research. Through its merger with P95, it combined Julius Clinical's expertise in global clinical development with P95's leadership in epidemiology, vaccines, infectious diseases, and real-world evidence. Together, they form a science-led global CRO with more than 500 professionals across 25+ countries.

A therapeutically specialized CRO combining the reach of a large CRO with the responsiveness of a mid-size partner.

1. 1The therapeutically specialized CRO | Julius Clinicaljuliusclinical.com
2. 2About Us | P95 Julius Clinicaljuliusclinical.com
3. 3Our Services | Julius Clinicaljuliusclinical.com